2587-7836

Pharmacokinetics and Pharmacodynamics

Publishing House OKI

View prefix report (10.37489)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 21 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact21 DOIs
2

Deposit reference lists for 2 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact2 DOIs
3

Attach ORCID iDs across 2 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact2 DOIs

DOIs for this ISSN

Showing the top 5 of 206 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The <i>in vitro</i> neuroprotective activity of… (10.37489/2587-7836-2020-2-4-10)
Abstract
21.13 6
2 Researches of the imidazole and indole derivatives cerebropr… (10.37489/2587-7836-2020-1-18-24)
Abstract
17.47 4
3 The effects of cycloprolylglycine and its analogues on brain… (10.37489/2587-7836-2020-1-3-10)
Abstract
17.47 4
4 Organizing of pharmacokinetic investigations (10.37489/2587-7836-2021-3-12-19)
Abstract
15.05 3
5 The relationship between the content of the potential psycho… (10.37489/2587-7836-2020-1-25-29)
Abstract
11.93 2
6 Perspective for the use of adamantane-type drugs for the tre… (10.37489/2587-7836-2021-3-3-11)
Abstract
11.93 2
7 Population pharmacokinetics analysis in Lixoft Monolix softw… (10.37489/2587-7836-2021-3-36-51)
Abstract
11.93 2
8 Screening study of nerve growth factor's and brain-derived n… (10.37489/2587-7836-2020-1-11-17)
Abstract
7.53 1
9 Alternative model Danio rerio for screening evaluation of th… (10.37489/2587-7836-2025-3-65-69)
ORCID
7.53 1
10 Senesens. Heart. Senotherapy (10.37489/2588-0519-2024-3-3-19)
References
7.53 1
11 Vladimir Pavlovich Zherdev: To the 80-th Anniversary (10.37489/10.37489/2587-7836-2026-1-80-81)
References ORCID
0.00 0
12 Study of ALM-802 orto-alkoxi analogues cardiotropic activity (10.37489/2587-7836-2019-4-18-23)
0.00 2
13 Antidepressant-like activity of the dipeptide mimetic of bra… (10.37489/2587-7836-2019-4-24-27)
0.00 0
14 HPLC-MS method development and validation for simultaneous q… (10.37489/2587-7836-2019-4-28-36)
0.00 1
15 Epac signaling protein ligands as tools for studying their b… (10.37489/2587-7836-2019-4-3-17)
0.00 0
16 Study of chronic toxicity of the GB-115 drug formulation (10.37489/2587-7836-2019-4-37-44)
0.00 0
17 Evaluation of allergenic properties and immunotoxicity of Ho… (10.37489/2587-7836-2019-4-45-48)
0.00 1
18 Evaluation of allergenic properties and immunotoxicity of di… (10.37489/2587-7836-2020-1-30-33)
Abstract
0.00 0
19 Study of acute toxicity of the drug Homeovox (10.37489/2587-7836-2020-1-34-41)
Abstract
0.00 0
20 Study of chronic toxicity of potential anxiolytic Homeovox (10.37489/2587-7836-2020-1-42-52)
Abstract
0.00 0
21 Study of acute and chronic toxicity of homeopathic syrup Sto… (10.37489/2587-7836-2020-1-53-58)
Abstract
0.00 0
22 Confirmation of validity of the developed translational mode… (10.37489/2587-7836-2020-2-11-16)
Abstract
0.00 0
23 The pharmacokinetics of the injectable dosage form of GK-2 i… (10.37489/2587-7836-2020-2-17-21)
0.00 1
24 An experimental study of the systemic bioavailability of the… (10.37489/2587-7836-2020-2-22-27)
Abstract
0.00 0
25 Analysis of sparse data in pharmacokinetic studies (10.37489/2587-7836-2020-2-28-33)
0.00 2
26 Evaluation of allergenic properties and immunotoxicity table… (10.37489/2587-7836-2020-2-34-36)
0.00 0
27 BDNF level role in formation of cognitive violations at midd… (10.37489/2587-7836-2020-2-37-41)
Abstract
0.00 0
28 About interrelations between levels of a neurotrophic factor… (10.37489/2587-7836-2020-2-42-48)
Abstract
0.00 0
29 The influence of the pharmacokinetics and bioavailability of… (10.37489/2587-7836-2020-3-25-29)
0.00 0
30 Statistical processing of pharmacological experiments result… (10.37489/2587-7836-2020-3-3-24)
0.00 5
31 Combined oral contraception and treatment of new coronavirus… (10.37489/2587-7836-2020-3-30-39)
0.00 0
32 Comparative study of the neuroprotective activity of lithium… (10.37489/2587-7836-2020-3-40-47)
0.00 2
33 Evaluation of immunotoxicity of the extended-release form of… (10.37489/2587-7836-2020-3-48-51)
0.00 0
34 Study the subchronic toxicity of the drug Dantinorm Baby (10.37489/2587-7836-2020-3-52-60)
0.00 1
35 Effect of the compound GIZH -290 and levetiracetam on epilep… (10.37489/2587-7836-2020-4-14-18)
0.00 0
36 Computer analysis of the emotional modality of 20 million pu… (10.37489/2587-7836-2020-4-19-40)
0.00 0
37 Pharmacokinetic relationships in psychotropic drugs effects (10.37489/2587-7836-2020-4-3-8)
0.00 0
38 The acute toxicity study GIZH-290 in mice (10.37489/2587-7836-2020-4-41-46)
0.00 0
39 Study of acute toxicity of GIZh-298 (10.37489/2587-7836-2020-4-47-53)
0.00 1
40 Effect of nerve growth factor dimeric mimetic GK-2 on microc… (10.37489/2587-7836-2020-4-9-13)
0.00 0
41 Comparative evaluation of echocardiographic characteristics… (10.37489/2587-7836-2021-1-14-17)
0.00 1
42 Cardioprotective effects of compound ALM-802 on subendocardi… (10.37489/2587-7836-2021-1-18-22)
0.00 3
43 Evaluation of the antitumor activity of 2-[3-(2-chloroethyl)… (10.37489/2587-7836-2021-1-23-29)
0.00 1
44 Determination of Serum/Plasma Concentrations of Psychotropic… (10.37489/2587-7836-2021-1-3-13)
0.00 3
45 On the mechanism of the antiarrhythmic action of fabomotizol… (10.37489/2587-7836-2021-1-30-37)
0.00 2
46 Study of the electrophysiological mechanisms of anticonvulsa… (10.37489/2587-7836-2021-1-38-44)
0.00 1
47 Development and validation of the method for the quantitativ… (10.37489/2587-7836-2021-1-45-51)
0.00 3
48 An approach to the quantitative determination of endogenous… (10.37489/2587-7836-2021-2-11-18)
0.00 2
49 Antiarrhythmic properties of N-Deacetyllappaconitine Hydroch… (10.37489/2587-7836-2021-2-19-24)
0.00 1
50 Effect of ethylmethylhydroxypyridine succinate on the functi… (10.37489/2587-7836-2021-2-25-30)
0.00 0